{"disease":{"id":"recurrent-mature-b-cell-neoplasms","name":"recurrent mature b cell neoplasms"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01704963","title":"A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Janssen Pharmaceutical K.K.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}